Review article: Single subject trials as a research instrument in gastrointestinal pharmacology

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 2, 2002, Pages 189-196

  Madsen, L G ^a   Bytzer, P ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; OMEPRAZOLE; PLACEBO; RANITIDINE;

CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG RESEARCH; GASTROENTEROLOGY; GASTROINTESTINAL DISEASE; HUMAN; METHODOLOGY; PHARMACOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; REVIEW; TREATMENT OUTCOME;

ANTI-ULCER AGENTS; CROSS-OVER STUDIES; DRUG ADMINISTRATION SCHEDULE; GASTROINTESTINAL DISEASES; HUMANS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0036166333     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01166.x     Document Type: Review

References (38)

1. A clinician's guide for conducting randomized trials in individual patients
2. Controlled trials in single subjects. 1 Value in clinical medicine
3. Deciding on the best therapy
4. Are frequent short gastrooesophageal reflux episodes the cause of symptoms in patients with non-ulcer dyspepsia responding to treatment with ranitidine?
5. Ranitidine for non-ulcer dyspepsia. A clinical study of the symptomatic effect of ranitidine and a classification and characterization of the responders to treatment
6. The multi-crossover model for classifying patients as responders to a given treatment
7. Ranitidine effectively relieves symptoms in a subset of patients with functional dyspepsia
8. Cimetidine responders in non-ulcer dyspepsia
9. The effect of cimetidine in non-ulcer dyspepsia. Experience with a multi-crossover model
10. The n-of-1 randomized controlled trial: Clinical usefulness. Our three years experience
11. Randomised study of n of 1 trials versus standard practice
12. Theophylline for irreversible chronic airflow limitation: A randomized study comparing n of 1 trials to standard practice
13. Cimetidine on-demand in dyspepsia. Experience with randomized controlled single-subject trials
14. Identifying responders to acid suppression in dyspepsia using a random starting day trial
15. Applying results of randomised trials to patients. N of 1 trials are needed
16. Single-patient randomised clinical trial. Use in determining optimum treatment for patient with inflammation of Kock continent ileostomy reservoir
17. The single-subject randomized trial. A useful clinical tool for assessing therapeutic efficacy in pediatric practice
18. An N-of-1 trial for treatment of hyperemesis gravidarum
19. Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: The use of the N of 1 randomized controlled trial
20. N of 1 trials. Managing patients with chronic fatigue syndrome: Two case reports
21. Clinical usefulness of amitriptyline in fibromyalgia: The results of 23 N-of-1 randomized controlled trials
22. N of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis
23. Feasibility study of N-of-1 trials with blood pressure self-monitoring in hypertension
24. A new study design explains lack of treatment efficacy in irritable bowel syndrome (IBS)
25. N of 1 randomised controlled trials of oral ketamine in patients with chronic pain
26. Double-blind methylphenidate trials: Practical, useful, and highly endorsed by families
27. N of 1 randomized trials for investigating new drugs
28. Testing nicotine gum for ulcerative colitis patients. Experience with single-patient trials
29. Dezinamide for partial seizures: Results of an n-of-1 design trial
30. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus
31. Effect of a new nootropic agent, CGS 5649B, on cognition, function, and behavior in dementia
32. Recombinant DNase in cystic fibrosis: A protocol for targeted introduction through n-of-1 trials
33. Interrater agreement of visual analysis in single-subject decisions: Quantitative review and analysis
34. An N of 1 service: Applying the scientific methods in clinical practice
35. Interpreting treatment effects in randomised trials
36. Statistical issues in studies of individual response
37. Combined single subject trials
38. Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment